Interaction of Na2B12H11SH with liposomes:: Influence on zeta potential and particle size

被引:18
|
作者
Awad, D [1 ]
Tabod, I
Lutz, S
Wessolowski, H
Gabel, D
机构
[1] Univ Bremen, Dept Chem, D-28334 Bremen, Germany
[2] Univ Bremen, Inst Environm Proc Engn, D-28334 Bremen, Germany
关键词
BSH; liposomes; liposome size; zeta potential;
D O I
10.1016/j.jorganchem.2005.01.013
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The interaction of Na2B12H11SH (BSH) with liposomes has been studied. BSH is a compound used clinically in boron neutron capture therapy of glioblastoma, and is known to enter tumor cells. Liposomes were used as a model for studying the interaction of BSH with cell membranes. BSH led to changes in the zeta potential of liposomes consisting of DODAB (dioctadecyldimethylammonium bromide) alone or with DOPC (dioleylphosphatidylcholine) or DOPE (dioleylphosphatidylethanolamine). It also led to changes of the size of DODAB liposomes, with a maximum size at small zeta potentials. A firm binding of BSH with the head groups of the lipid must be assumed. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:2732 / 2735
页数:4
相关论文
共 50 条
  • [1] Interaction of Na2B12H11SH with dimyristoyl phosphatidylcholine liposomes
    Awad, Doaa
    Damian, Luminita
    Winterhalter, Mathias
    Karlsson, Goeran
    Edwards, Katarina
    Gabel, Detlef
    CHEMISTRY AND PHYSICS OF LIPIDS, 2009, 157 (02) : 78 - 85
  • [2] Determination of BSH (Na2B12H11SH) absorbed in tumor tissue
    Nakagawa, Y
    Pooh, K
    Sone, M
    Kageji, T
    Nakaichi, M
    Takahashi, H
    Amemiya, K
    Gabel, D
    FRONTIERS IN NEUTRON CAPTURE THERAPY, VOLS 1 AND 2, 2001, : 933 - 937
  • [3] Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH
    Gilbert, B
    Perfetti, L
    Fauchoux, O
    Redondo, J
    Baudat, PA
    Andres, R
    Neumann, M
    Steen, S
    Gabel, D
    Mercanti, D
    Ciotti, MT
    Perfetti, P
    Margaritondo, G
    De Stasio, G
    PHYSICAL REVIEW E, 2000, 62 (01): : 1110 - 1118
  • [4] Subcellular biodistribution of Na2B12H11SH (BSH) in rat glioma model
    Kageji, T
    Nagahiro, S
    Matsumoto, K
    Otersen, B
    Gabel, D
    Nakaichi, M
    Nakagawa, Y
    FRONTIERS IN NEUTRON CAPTURE THERAPY, VOLS 1 AND 2, 2001, : 927 - 931
  • [5] Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors
    Teruyoshi Kageji
    Yoshinobu Nakagawa
    Katsuji Kitamura
    Keizo Matsumoto
    Hiroshi Hatanaka
    Journal of Neuro-Oncology, 1997, 33 : 117 - 130
  • [6] Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors
    Kageji, T
    Nakagawa, Y
    Kitamura, K
    Matsumoto, K
    Hatanaka, H
    JOURNAL OF NEURO-ONCOLOGY, 1997, 33 (1-2) : 117 - 130
  • [7] Systemic hyaluronidase:: A promising adjuvant for BNCT of glioblastoma with Na2B12H11SH (BSH)
    Haselsberger, K
    Radner, H
    Pendl, G
    ADVANCES IN NEUTRON CAPTURE THERAPY, VOLS I AND II: VOL I: MEDICINE AND PHYSICS, VOL II: CHEMISTRY AND BIOLOGY, 1997, 1132 : B202 - B204
  • [8] NEUTRON-INDUCED TRACK ETCH AUTORADIOGRAPHY OF THE THERAPEUTIC COMPOUND (NA2B12H11SH)-B-10
    KIRSCH, JE
    BROWNELL, GL
    MEDICAL PHYSICS, 1981, 8 (05) : 736 - 736
  • [9] SUBCELLULAR B-10 LOCALIZATION IN GLIOBLASTOMA FOR BORON NEUTRON-CAPTURE THERAPY WITH NA2B12H11SH
    HASELBERGER, K
    RADNER, H
    GOSSLER, W
    SCHLAGENHAUFEN, C
    PENDL, G
    JOURNAL OF NEUROSURGERY, 1994, 81 (05) : 741 - 744
  • [10] Quality control of Na2B12H11SH, a drug for boron neutron capture therapy in eortc trial 11961
    Gabel, D
    Touw, D
    Stecher-Rasmussen, F
    Huiskamp, R
    Sauerwein, W
    FRONTIERS IN NEUTRON CAPTURE THERAPY, VOLS 1 AND 2, 2001, : 257 - 260